BBC / ETFis Series Trust I - Virtus Biotech Clinical Trials ETF - Net Long/Short Value

ETFis Series Trust I - Virtus Biotech Clinical Trials ETF
US ˙ ARCA

BBC / ETFis Series Trust I - Virtus Biotech Clinical Trials ETF - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
LPL Financial LLC
Kera Capital Partners, Inc.
Federation des caisses Desjardins du Quebec
Aurora Private Wealth, Inc.
Larson Financial Group LLC
Advisor Group Holdings, Inc.
Citadel Advisors Llc
Jane Street Group, Llc
Militia Capital Partners, LP
Morgan Stanley
Militia Capital Management LLC
Susquehanna International Group, Llp
Dynamic Wealth Strategies, LLC
Blair William & Co/il
New England Capital Financial Advisors LLC
Allworth Financial LP
Quantinno Capital Management LP
Flow Traders U.s. Llc
Global Assets Advisory, LLC
UBS Group AG
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista